Medical Devices - Reporting to MHRA.. Emma Rooke, December 2015

Similar documents
GPvP Symposium 2014: Welcome and Updates. 14 March 2014 Rebecca Stanbrook, Group Manager Inspections (GCP/GPvP/GLP)

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018

Case-by-Case Regulatory toxicology testing in Drug Development in Rare or Debilitating Disease

Direct-to-consumer devices and the DIY community

Guidance for Industry

Industry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee

Immediate action Action Update Information request

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

Online Form. Welcome to the Integrated Research Application System. IRAS Project Filter

Information provided to Duchenne muscular dystrophy patient organisations regarding Raxone

I M REGISTERED. Promoting your status as a registered health professional. A guide for osteopaths

Standard Operating Procedure Research Governance

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

How is the introduction of a new medicine regulated in the UK?

About this consent form

USE OF UNLICENSED MEDICINES AND OFF-LABEL MEDICINES WHERE A LICENSED MEDICINE IS AVAILABLE

SINGLE USE MEDICAL DEVICES POLICY

Thank you for your requests under the Freedom of Information Act Please find below responses to your questions.

NHS Breast Screening Programme

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

Automated external defibrillators

40 Use and Supply of Drugs or Medicines in Optometric Practice

STATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015

MEDICAL DEVICES. our advice on. automated external. defibrillators

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy

Medicines in Scotland: What s the right treatment for me? Information for patients and the public

EXPERIENCE THE WORLD S FIRST TRULY SMART HEARING DEVICE

AMERICAN CANCER SOCIETY FUNDRAISING APP FAQS

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK. Presented by: Mariam Aslam

Guide to Interchangeable Medicines

2014 Maladministration investigation procedures

PrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1

A Guide to the Scottish Medicines Consortium

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Workplace Fundraising Information Pack

Day care and childminding: Guidance to the National Standards

Group Leaders Guidance

Consultation on revised threshold criteria. December 2016

Name of Event: Date of Event: Details of Event Organiser: [Name, Address, Contact number, ]

Parkinson s UK Brain Bank: answering your questions about brain donation. In association with

STANDARD OPERATING PROCEDURE

Guidelines for the Recall or Withdrawal of a Medical Product

REPORTING ADVERSE INCIDENTS GUIDANCE ON NEW ARRANGEMENTS FOR NHS WALES ORGANISATIONS

Bupa Dental Plan To find out more or to apply over the telephone call

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210

Autism Action Network Charter

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Subject: Temporary importation of Hartmann s (Compound Sodium Lactate) 1L from Spain to address manufacturing disruption in UK

How will being a member of Physio First benefit you?

Enhanced Asthma Management with Mobile Communication

AfterCare Program for Childhood Cancer Survivors

This guidance is designed to give housing associations the tools to implement the Commitment to Refer. It is structured into eight parts:

STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA

The new laws. Why are the laws changing? From 1st April 2011, it will also be illegal:

FLIPS FreeStyle Libre in Pregnancy Study

A New Participant s Guide to CVA Qualification

Using medicines beyond licence

BSL communication support during pregnancy and birth

Potential Grounds for Revocation of a Traditional Herbal Registration

EUROPEAN MEDICINES AGENCY SCI E N C E M E D I C I N E S H ealth. Public hearings. Guidance for participants

Research & Development. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Our raffles comply with the following policies:

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

Guidance on Medical Devises Bundling / Grouping Criteria MDS-G7 MDS G7. Guidance on Medical Devices Bundling/ Grouping Criteria

The Danish Medicines Agency s availability strategy

ISO 13485:2016 Medical Devices Training Handbook

Guide to Professional Conduct and Ethics for Registered Medical Practitioners. Relationships between doctors and industry Frequently Asked Questions

Autologous plasma eye drops. Patient information

EMPOWERING WOMEN. EXPANDING AWARENESS. ERADICATING VIOLENCE.

Open Range Software, LLC

Consent to research. A draft for consultation

PATIENT GROUP DIRECTION PROCEDURE

Guidance for optometrist prescribers

XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION

NHS breast screening NHS BCS Fact booklet_aw_cs4.indd 1 29/12/ :51

UK experience with the traditional herbal registration scheme

Physiotherapy Tender Questions and Answers

Lincolnshire Credit Union Ltd. Report to Boston Big Local Partnership. Developing and supporting the Credit Union Access Point.

Medical Devices and Active Implantable Medical Devices

The Irish Cancer Society The Irish Cancer Society. The Irish Cancer Society. cancer.ie callsave

Continuous Glucose Monitoring

Diabetes Management in hospital care: GlucoTab - A medical device to improve insulin treatment of patients with diabetes type 2

Section 32: BIMM Institute Student Disciplinary Procedure

8.0 ADVERSE EVENT HANDLING

A helping hand when you need it most

Use of Assistive Devices by the General Public Procedure Page 1 of 6

The European Medicines Agency (EMA)

SOP-QA-30 V Scope

11. NATIONAL DAFNE CLINICAL AND RESEARCH DATABASE

MHRA Pharmacovigilance System Master File (PSMF) Inspection Findings

2013 Maladministration investigation procedures

REGULATORY ENVIRONMENT FOR MEDICAL DEVICES IN NEW ZEALAND

NEWSLETTER October The Pharmacovigilance Risk Assessment Committee July (PRAC) Meeting

A cancer diagnosis can make you feel like your world has been turned upside down. It can also impact your finances. Here at Halifax, we have a

Share/Follow. User Guide. A feature of Dexcom G5 Mobile CGM System

ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]

Improving medication safety

Childminding: Guidance to the National Standards

Transcription:

Medical Devices - Reporting to MHRA. Emma Rooke, December 2015

Topics to be covered today: The MHRA and what we do What is a Medical Device? Adverse Incidents Reporting adverse incidents to the MHRA

The Medicines and Healthcare Products Regulatory Agency Clinical Practice Research Datalink National Institute for Biological Standards and Control

What we do (not exhaustive!) Medicines (inc herbal and homeopathic) Licence Monitor adverse incidents Enforce regulations Medical Devices Monitor Notified Bodies Monitor adverse incidents Enforce regulations Blood Establishments & Blood Banks Authorise Monitor adverse incidents Enforce regulations

MHRA Publications

What is a Medical Device? Any instrument, apparatus, appliance, material or other article to be used for human beings for the purpose of: - diagnosis, prevention, monitoring, treatment or alleviation of disease, - diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap, - investigation, replacement or modification of the anatomy or of a physiological process, - control of conception, and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means;

Adverse Incidents

What is an Adverse Incident? An event that causes, or has the potential to cause, unexpected or unwanted effects involving the safety of patients, users or other persons.

What to report Report to MHRA when a) the problem involves a medical device and b) the problem with/failure of the product has caused or could have caused injury If in doubt, please report it! 9

Medical devices you may come across can include: Powered wheelchairs Mobility Scooters Oxygen Concentrators Electrically powered medical devices 10

Who should report and when? Anyone! Clinicians, Suppliers, Patients, Medical Device Liaison Officers, Manufacturers If you would like to discuss it first, get in touch: MHRA Adverse Incident Centre Tel: 020 3080 7080, aic@mhra.gsi.gov.uk Please report any issues as soon as possible, providing as much detail as you can 11

How to report Visit our website www.mhra.gsi.gov.uk 12

Yellow card scheme - now covers Medical Devices too 13

Please include: Manufacturer, device type and model name Without these the manufacturer cannot investigate MHRA will not be able to determine whether your report is part of a wider problem Details of what happened Who MHRA and the manufacturer can contact for further information about the incident report 14

What happens next? We will tell you within 10 working days of receipt of your report what we plan to do We will always: send your report to the manufacturer for their internal investigation add your report to our database Our database is reviewed regularly to identify patterns where further action is needed 15

We do not investigate every report Therefore, please do not automatically expect updates from us The manufacturer will carry out an internal investigation Please provide them with any details they request, and contact them for their findings 16

When do MHRA investigate? When we receive a report of death or serious injury or When the manufacturer s investigation indicates a wider problem or When we detect a pattern in reported problems If we decide to do this, we will let you know and keep you informed of our progress 17

What does an MHRA investigation involve? We may ask the manufacturer for details of their findings ask them to investigate further ask them to consider corrective action 18

Why should I report? If problems are not reported, they won t be resolved MHRA investigations can result in: Changes to design/instructions Safety related warnings/advice being issued Education to reduce use-errors Field Safety Corrective Actions Removal from the market 19

Why your report counts Receipt of 13,282* reports in 2014 resulted in the following actions:- 104 design modifications 130 labelling/instructions-for-use changes 26 cases of production being ceased 341 manufacturer undertakings to manufacturing process and quality assurance 42 medical device alerts issued *Total incidents reported includes periodic summary reports

Crown copyright 2015 About copyright All material created by the Medicines and Healthcare Products Regulatory Agency, including materials featured within these Medicines and Healthcare Products Regulatory Agency presentation notes and delegate pack, is subject to Crown copyright protection. We control the copyright to our work (which includes all information, database rights, logos and visual images), under a delegation of authority from the Controller of Her Majesty s Stationery Office (HMSO). The Medicines and Healthcare Products Regulatory Agency authorises you to make one free copy, by downloading to printer or to electronic, magnetic or optical storage media, of these presentations for the purposes of private research, study and reference. Any other copy or use of Crown copyright materials featured on this site, in any form or medium is subject to the prior approval of the Medicines and Healthcare Products Regulatory Agency. Further information, including an application form for requests to reproduce our material can be sought from copyright@mhra.gsi.gov.uk Material from other organisations The permission to reproduce Crown copyright protected material does not extend to any material in this pack which is subject to a separate licence or is the copyright of a third party. Authorisation to reproduce such material must be obtained from the copyright holders concerned.

If you have any questions, please get in touch MHRA Adverse Incident Centre aic@mhra.gsi.gov.uk Tel: 020 3080 7080 Thank you 22